By contrast, transcript-level silencing of YAP1 and WWTR1 has been reported in hematological cancers such as multiple myeloma (MM) (28, 29) and NE cancers such as medullary thyroid cancer (30–32), NE prostate cancer (33), and small cell lung cancer (SCLC) (34–37). Here, YAP1 is linked to Familial prostate cancer.